Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T2 Biosystems developed and commercialized rapid molecular diagnostic tests using its proprietary magnetic resonance technology. Its FDA-cleared products included the T2Candida Panel and the T2Bacteria Panel for direct-from-blood identification of fungal and bacterial bloodstream infections. The company also advanced a pipeline including a resistance gene panel, a biothreat panel, a Candida auris panel, and a Lyme disease test. Clinical studies demonstrated improved speed to result compared to traditional blood cultures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T2 Biosystems.